Contemporary issues affecting P&T committees Part I: The evolution

P and T

Volumn 29, Issue 11, 2004, Pages 709-711

  Balu, Sanjeev ^a   O'Connor, Paul ^b   Vogenberg, F Randy ^b  

^a PURDUE UNIVERSITY   (United States)

^b Aon Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCREDITATION; ADVERSE DRUG REACTION; COST CONTROL; DECISION MAKING; DOSE CALCULATION; DRUG COST; DRUG EFFICACY; DRUG FORMULARY; DRUG INFORMATION; DRUG MARKETING; DRUG NOMENCLATURE; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEALTH CARE QUALITY; HEALTH SERVICE; MANAGED CARE; MANAGED CARE ORGANIZATION; PATIENT COMPLIANCE; SHORT SURVEY; STANDARDIZATION;

EID: 9644300991     PISSN: 10521372     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (21)

1. Lipman AG. Drug use management. In: Brown TR, ed. Handbook of Institutional Pharmacy Practice, 3rd ed. Bethesda, MD: American Society of Hospital Pharmacists, 1992:63-71.
2. Principles of a Sound Drug Formulary System. Formulary Management-Endorsed Document 2000:139-142. Available at: www.ashp.org.
3. American Society of Hospital Pharmacists. ASHP statement on the pharmacy and therapeutics committee. Am J Hosp Pharmacy 1992;49:2008-2009.
4. Worthen DB. Andrew Craigie (1754-1819), America's First Apothecary General. J Am Pharmaceut Assoc 2002;42(5):811-813.
5. Instititue of Medicine. Description and Analysis of the VA National Formulary. Washington, DC: National Academies Press; 2000. Available at: www.iom.edu and http://books.nap.edu/books/0309069866/html/16.html.
6. Sax MJ, Emigh R. Managed care formularies in the United States. J Managed Care Pharmacy July/August 1999. Available at: www.amcp.org/data/jmcp/vol5/num4/ managed.html.
7. Francke DE. Mirror to Hospital Pharmacy. Washington, DC: American Society of Hospital Pharmacists; 1964:139-140. Excerpted in Francke DE, et al. Am J Hosp Pharm 1986;43:2838-2839.
8. Francke DE. Mirror to Hospital Pharmacy. Washington, DC: American Society of Hospital Pharmacists; 1964:139-140. Excerpted in Francke DE, et al. Am J Hosp Pharm 1986;43:2838-2839.
9. Sonnedecker G. The American practice of pharmacy, 1902-1952. J Am Pharm Assoc 2001;41:21-23.
10. Higby GJ. Evolution of pharmacy. In: Gennaro AR, ed. Remington: The Science and Practice of Pharmacy. Baltimore, MD: Lippincott Williams & Wilkins; 2000:7-18.
11. Cohen H. Pharmacy in the new millennium: The evolving role of the hospital pharmacist. Pharmacy Net Guide December 2002. Available at: http://pharmacynetguide.com/archives/v1n1/Cover_intro.html.
12. Higby GJ. The continuing evolution of American pharmacy practice, 1952-2002. J Am Pharm Assoc 2002;42(1):12-15.
13. Goldberg RB. Managing the pharmacy benefit: the formulary system. J Managed Care Pharm 1997;3(5):565-573.
14. Cross M. Increased pressures change P&T committee makeup. Managed Care. December 2001.
15. Steger JW, Wolveton SE, Greenberg RD, et al. Guidelines of care for dermatologic drug formulary. J Am Acad Dermatol 1996;34:99-109. Available at: www.aadassociation.org/Guidelines/drugform.html.
16. 1994 Accreditation Manual for Hospitals, Vol 1. Standards. Oakbrook Terrace IL: Joint Commission on Accreditation of Healthcare Organizations, 1993.
17. Rich DS. New JCAHO Medication management standards for 2004. Am J Health Syst Pharm 2004;61(3):1349-1358.
18. Medical Interface's Facts & Figures. Bronxville, NY: Medicom International, 1996.
19. Shepherd MD, Salzman RD. The formulary decision-making process in a health maintenance organization setting. Pharmacoeconomics 1994;5(1):29-38.
20. Taniguchi R. Pharmacy benefit management companies. Am J Health Syst Pharm 1995;52(17):1915-1917.
21. About the P&T Society. Available at www.ptsociety.org/abo.htm.